MedPath

HETERO AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

60

TGA:60

Drug Approvals

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, bottle pack (297926)

Product Name
CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, HDPE bottle pack
Approval Date
Dec 13, 2022
TGA

BACAMID 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297930)

Product Name
BACAMID 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack
Approval Date
Dec 13, 2022
TGA

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297920)

Product Name
CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, Alu-Alu blister pack
Approval Date
Dec 13, 2022
TGA

ABADINE 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, bottle pack (297932)

Product Name
ABADINE 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, HDPE bottle pack
Approval Date
Dec 13, 2022
TGA

ABADINE 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297921)

Product Name
ABADINE 600/300 Abacavir (as sulfate) and Lamivudine 600 mg/300 mg tablets blister pack
Approval Date
Dec 13, 2022
TGA

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297931)

Product Name
CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack
Approval Date
Dec 13, 2022
TGA

BACAMID 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, bottle pack (297925)

Product Name
BACAMID 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, HDPE bottle pack
Approval Date
Dec 13, 2022
TGA

LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297929)

Product Name
LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, Alu-Alu blister pack
Approval Date
Dec 13, 2022
TGA

ABADINE 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297928)

Product Name
ABADINE 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack
Approval Date
Dec 13, 2022
TGA

LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297934)

Product Name
LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, PVC/PVdC-Alu blister pack
Approval Date
Dec 13, 2022
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.